Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
T7 RNA Polymerase for RNA Therapeutic Workflows
2026-09-17
Build reproducible RNA workflows for mRNA, probes, ribozymes, and RNAi using a promoter-specific transcription system. This guide connects template design and quality control with the inhaled RNA strategy reported for remodeling the lung tumor microenvironment.
-
EGCG Nanoparticles Enhance FLASH-RT Antitumor Effects
2026-09-16
A 2026 International Journal of Nanomedicine study developed functionalized self-assembled EGCG nanoparticles (BENPs) to sensitize 4T1 tumors to FLASH radiotherapy. The combination increased radiation-associated ROS and DNA damage while also promoting antitumor immune responses, providing a mechanistic framework for improving FLASH-RT without simply escalating radiation exposure.
-
GDC-0068 (RG7440) Workflow for Akt–mTOR Assays
2026-09-15
GDC-0068 (RG7440) provides a selective pan-AKT perturbation strategy for linking PI3K/Akt/mTOR signaling to phosphorylation, proliferation, cell-cycle behavior, and tumor-cell survival. Its greatest value emerges when acute pathway assays are paired with spatially targeted mTORC1 tools to distinguish global Akt dependence from compartment-specific signaling.
-
DAPI (hydrochloride) Workflows for DNA Analysis
2026-09-15
DAPI (hydrochloride) combines sequence-biased nuclear labeling with practical utility in microscopy, flow cytometry, chromosome staining, and infection-model readouts. This guide translates its chemistry into reproducible workflows for fixed and live cells, including an assay framework inspired by erythrocyte-mimicking nanovesicles targeting Porphyromonas gingivalis.
-
Dual HER2–VEGFR-2 Targeting in TNBC
2026-09-14
The 2026 reference study evaluates Lapatinib and Telatinib as a dual tyrosine kinase inhibition strategy in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Its phenotype-first findings connect treatment with reduced invadopodia formation, cell proliferation, and two-dimensional tube formation, while emphasizing that functional response does not by itself prove direct HER2 engagement.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-09-14
The reference study identifies O-GlcNAcylation as a necessary metabolic mediator of Wnt-stimulated osteogenesis rather than a passive consequence of increased glucose flux. Its central mechanism links Wnt3a to PDK1 Ser174 modification, PDK1 stabilization, enhanced aerobic glycolysis, and bone formation, with implications for fracture repair and anabolic osteoporosis research.
-
MitMAB for Organoid Endocytosis Research
2026-09-13
MitMAB provides a practical way to test whether extracellular-vesicle uptake depends on dynamin-driven vesicle scission. In polarized intestinal organoids, it helps connect uptake measurements with epithelial orientation, regional biology, barrier status, and intracellular trafficking research.
-
DAPI (hydrochloride) in Translational Cell Biology
2026-09-12
DAPI (hydrochloride), also known as 4',6-diamidino-2-phenylindole hydrochloride, is more than a routine nuclear counterstain. This article examines how its DNA-binding mechanism can strengthen translational studies of MPP7, epithelial–mesenchymal transition, cell polarity, and ovarian cancer while clarifying what the dye can—and cannot—prove.
-
Acetylcysteine for ROS/NF-κB Cell Assays
2026-09-12
Acetylcysteine enables controlled redox rescue experiments, from cochlear senescence assays to hepatic, respiratory, and neurodegenerative models. This workflow-focused guide explains how to select concentrations, separate antioxidant effects from toxicity, and translate NAC findings into defensible experimental decisions.
-
Fasudil and Hippo Signaling: A Translational ROCK Strategy
2026-09-11
Fasudil (HA-1077) HCl is more than a catalog ROCK inhibitor: it is a practical perturbation tool for separating cytoskeletal signaling, proliferation, migration, and apoptosis. By placing Fasudil alongside the 2025 quercetin–Hippo cataract study, this article defines a disciplined path from pathway observation to translational experiment without overstating cross-domain evidence.
-
Separating Caspase-6 Apoptosis from Pyroptosis
2026-09-11
A translational framework for using Z-VEID-FMK to distinguish caspase-6-dependent apoptosis from caspase-1-driven pyroptosis in neuronal and cancer models, informed by recent HOXC8 research in NSCLC.
-
Quercetin, Hippo Signaling, and Cataract Protection
2026-09-10
A 2025 study integrates network pharmacology, a UVB-induced cataract mouse model, and hydrogen peroxide-injured lens epithelial cells to investigate how quercetin protects the lens. Its findings link reduced oxidative stress and improved epithelial-cell survival to suppression of Hippo pathway activity, while pharmacologic pathway reactivation weakened these effects.
-
HEY2, Mitochondrial Respiration, and Cardiac Homeostasis
2026-09-10
The reference study identifies HEY2 as an inducible transcriptional brake on mitochondrial oxidative metabolism in cardiomyocytes. By combining disease-associated human samples with zebrafish, mouse, and cell-based perturbation models, it connects HEY2–HDAC1 repression of Ppargc1 and Cpt-related programs to reactive oxygen species, cardiomyocyte loss, and heart failure, while showing that targeted restoration of metabolic regulators can improve bioenergetic defects.
-
Influenza Hemagglutinin (HA) Peptide Workflow Guide
2026-09-09
Use the Influenza Hemagglutinin (HA) Peptide to release HA-tagged proteins from antibody capture systems under comparatively mild, tunable conditions. This practical guide covers immunoprecipitation, interaction studies, exosome-related assays, optimization, and troubleshooting.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-09-09
Borchert et al. connected homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma models. The study highlights BAP1-associated BRCAness as a potential basis for treatment stratification while identifying AURKA, RAD50, and DDB2 as prognostic candidates.